201 related articles for article (PubMed ID: 16148610)
21. Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action.
Inada Y; Ojima M; Kanagawa R; Misumi Y; Nishikawa K; Naka T
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S75-80. PubMed ID: 10076925
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
[TBL] [Abstract][Full Text] [Related]
23. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
Foucart S; Patrick SK; Oster L; de Champlain J
Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
[TBL] [Abstract][Full Text] [Related]
24. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
[TBL] [Abstract][Full Text] [Related]
26. KT3-671, an angiotensin AT1 receptor antagonist, attenuates vascular but not cardiac responses to sympathetic nerve stimulation in pithed rats.
Takata Y; Kurihara J; Yoda T; Suzuki S; Matsuoka Y; Okubo Y; Kato H
J Cardiovasc Pharmacol; 2001 Apr; 37(4):427-36. PubMed ID: 11300656
[TBL] [Abstract][Full Text] [Related]
27. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic studies on the angiotensin II type 1 antagonists irbesartan and candesartan based on angiotensin II dose response in humans.
Belz GG; Butzer R; Kober S; Mutschler E
J Cardiovasc Pharmacol; 2002 Apr; 39(4):561-8. PubMed ID: 11904530
[TBL] [Abstract][Full Text] [Related]
29. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.
Christophe B; Libon R; Cazaubon C; Nisato D; Manning A; Chatelain P
Eur J Pharmacol; 1995 Aug; 281(2):161-71. PubMed ID: 7589203
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II receptor pharmacology and AT1-receptor blockers.
Chung O; Csikós T; Unger T
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S11-20; discussion S33-4. PubMed ID: 10076916
[TBL] [Abstract][Full Text] [Related]
31. Vasopressin-induced presynaptic facilitation of sympathetic neurotransmission in the pithed rat.
Streefkerk JO; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2002 Jun; 20(6):1175-80. PubMed ID: 12023688
[TBL] [Abstract][Full Text] [Related]
32. Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.
Richer C; Domergue V; Vincent MP; Giudicelli JF
Br J Pharmacol; 1996 Jan; 117(2):315-24. PubMed ID: 8789385
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M
Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498
[TBL] [Abstract][Full Text] [Related]
34. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
Junggren IL; Zhao X; Sun X; Hedner T
J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of action of angiotensin II is dependent on direct activation of vascular smooth muscle carbonic anhydrase I.
Puscas I; Coltau M; Gilau L; Baican M; Pasca R; Domuta G; Hecht A
Int J Clin Lab Res; 2000; 30(3):119-25. PubMed ID: 11196069
[TBL] [Abstract][Full Text] [Related]
37. Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data.
Mallion JM; Badguet JP
J Hum Hypertens; 2000 Oct; 14 Suppl 2():S33-41. PubMed ID: 11086634
[TBL] [Abstract][Full Text] [Related]
38. Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles.
Hong K; Zhao G; Hong Z; Sun Z; Yang Y; Clifford PS; Davis MJ; Meininger GA; Hill MA
J Physiol; 2016 Dec; 594(23):7027-7047. PubMed ID: 27531064
[TBL] [Abstract][Full Text] [Related]
39. The pharmacological potency of various AT(1) antagonists assessed by Schild regression technique in man.
Belz GG; Breithaupt-Grögler K; Butzer R; Fuchs W; Hausdorf C; Mang C
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):336-41. PubMed ID: 11967820
[TBL] [Abstract][Full Text] [Related]
40. Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats.
Ruiz-Gayo M; Somoza B; Bravo R; Fernández-Alfonso MS; González C
Life Sci; 2000 Nov; 67(26):3153-62. PubMed ID: 11191622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]